We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

527 hedge funds and large institutions have $16B invested in Abiomed Inc in 2018 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 157 increasing their positions, 171 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

428% more first-time investments, than exits

New positions opened: 153 | Existing positions closed: 29

40% more funds holding in top 10

Funds holding in top 10: 15 → 21 (+6)

40% more capital invested

Capital invested by funds: $11.5B → $16B (+$4.55B)

30% more funds holding

Funds holding: 405 → 527 (+122)

8% less repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 171

21% less call options, than puts

Call options by funds: $167M | Put options by funds: $212M

Holders
527
Holders Change
+122
Holders Change %
+30.12%
% of All Funds
12.07%
Holding in Top 10
21
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+40%
% of All Funds
0.48%
New
153
Increased
157
Reduced
171
Closed
29
Calls
$167M
Puts
$212M
Net Calls
-$45.4M
Net Calls Change
-$39.3M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$297M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$210M
3
State Street
State Street
Massachusetts
+$158M
4
Renaissance Technologies
Renaissance Technologies
New York
+$146M
5
Two Sigma Investments
Two Sigma Investments
New York
+$138M

Top Sellers

1
BlackRock
BlackRock
New York
-$315M
2
Winslow Capital Management
Winslow Capital Management
Minnesota
-$284M
3
PAI
Palo Alto Investors
California
-$165M
4
William Blair Investment Management
William Blair Investment Management
Illinois
-$154M
5
American Century Companies
American Century Companies
Missouri
-$136M
Name Holding Trade Value Shares
Change 		Change in
Stake
EP
226
Elkfork Partners
Oregon
$3.1M +$343K +946 +14%
Citigroup
227
Citigroup
New York
$2.97M +$1.8M +4,962 +215%
UONDDL
228
University of Notre Dame du Lac
Indiana
$2.96M -$1.17M -3,226 -31%
EU
229
Emory University
Georgia
$2.89M +$2.56M +7,065 New
NAM
230
Nissay Asset Management
Japan
$2.85M +$2.52M +6,955 New
CGH
231
Crossmark Global Holdings
Texas
$2.84M +$266K +733 +12%
KCM
232
Kornitzer Capital Management
Kansas
$2.82M +$2.5M +6,895 New
SAM
233
Shell Asset Management
Netherlands
$2.81M +$1.23M +3,391 +97%
SOADOR
234
State of Alaska Department of Revenue
Alaska
$2.81M +$1.12M +3,100 +82%
RHBC
235
R.H. Bluestein & Co
Michigan
$2.79M -$4.19M -11,575 -63%
AIM
236
Achmea Investment Management
Netherlands
$2.73M +$2.42M +6,671 New
MSV
237
MN Services Vermogensbeheer
Netherlands
$2.7M +$2.39M +6,600 New
AB
238
Amalgamated Bank
New York
$2.69M -$946K -2,612 -28%
HIMCH
239
Hartford Investment Management Co (HIMCO)
Connecticut
$2.61M +$2.31M +6,379 New
Mitsubishi UFJ Asset Management
240
Mitsubishi UFJ Asset Management
Japan
$2.59M +$1.97M +5,430 +595%
RCM
241
Riverhead Capital Management
Delaware
$2.57M +$282K +779 +14%
Skandinaviska Enskilda Banken (SEB)
242
Skandinaviska Enskilda Banken (SEB)
Sweden
$2.53M +$2.24M +6,189 New
TRSOTSOK
243
Teachers Retirement System of the State of Kentucky
Kentucky
$2.52M -$732K -2,020 -25%
Northwestern Mutual Wealth Management
244
Northwestern Mutual Wealth Management
Wisconsin
$2.52M -$47.8K -132 -2%
DekaBank Deutsche Girozentrale
245
DekaBank Deutsche Girozentrale
Germany
$2.52M +$2.13M +5,870 New
DILIC
246
Dai-ichi Life Insurance Company
Japan
$2.46M +$2.18M +6,019 New
SSWM
247
Sheets Smith Wealth Management
North Carolina
$2.45M +$31.2K +86 +1%
Mirae Asset Global Investments
248
Mirae Asset Global Investments
South Korea
$2.44M -$277K -765 -11%
MSA
249
Mason Street Advisors
Wisconsin
$2.42M -$5.51M -15,199 -72%
MOACM
250
Mutual of America Capital Management
New York
$2.39M -$10.7M -29,495 -83%
8 9
10
11 12

ABMD Hedge Fund Activity: Q2 2018 in Review

527 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2018, worth a combined $16B — up 40% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 153 funds opened new ABMD positions and 29 closed out — a net gain of 124 holders — while 157 added to existing stakes and 171 trimmed.

The largest buyer was Vanguard Group, adding an estimated $297M. The largest seller was BlackRock, cutting an estimated $315M.

  • 527 institutional investors held Abiomed Inc (ABMD) as of Q2 2018, up from 405 in Q1 2018.
  • Funds reported $16B of Abiomed Inc stock for Q2 2018, up 40% quarter-over-quarter.
  • 153 funds opened new Abiomed Inc positions in Q2 2018 and 29 closed out, a net change of +124 holders.
  • The largest Abiomed Inc buyer in Q2 2018 was Vanguard Group, an estimated $297M added.
  • The largest Abiomed Inc seller in Q2 2018 was BlackRock, an estimated $315M sold.

Based on aggregated 13F filings for Q2 2018.